IDIC Affiliate Scientist
Dr. Hodara has amassed over 30 years of experience in the field of medical sciences, with a specialized focus on virology and immunology studies. Her research involves utilizing various methodologies such as cell culture, immunohistochemistry, and flow cytometry techniques. Presently, Dr. Hodara is actively engaged in collaborative research initiatives, including investigations utilizing the SIV (simian immunodeficiency virus) model for studying HIV in rhesus macaques and baboons, as well as research on Zika virus infection in marmosets.
Additionally, Dr. Hodara oversees and contributes to several collaborative projects, particularly in the areas of flow cytometry and immunology, encompassing a diverse range of nonhuman primate species including rhesus macaques, pigtail macaques, African green monkeys, cynomolgus macaques, baboons, and marmosets. These projects extend to the study of various viruses such as TB, Dengue, Ebola-Marburg, Zika, and Covid-19.
Other collaborative projects overseen by Dr Hodara, are the flow cytometry and immunology efforts for the National Primate Center located at Texas Biomedical Institute, involving various nonhuman primates (rhesus, pigtail, African green monkey, cynomolgus macaques, baboons, marmosets) and TB, Dengue, Ebola-Marburg, Zika and Covid19 viruses. She collaborates in identifying reagents compatible with different non-human primates (NHPs) and adapting methodologies from human or mouse studies to suit NHP models.
Viral infection and immune responses:
AIDS pathogenesis research:
Infection of rhesus macaques with simian immunodeficiency virus (SIV) is the preferred animal model for the development and testing of human immunodeficiency virus (HIV) vaccines. Animals protected from SIV challenge by live attenuated vaccines are an invaluable tool for determining immune correlates of protection.
Studies on the acute infection with pathogenic virus in the rhesus macaque/ SIV model first documented evidence that the innate immune system of rhesus macaques recognizes SIV infection by sequential production of pro-inflammatory cytokines and transient activation of NK cytotoxic activity. We identified the active role of NK cells during the acute phase of infection and demonstrated a novel application of a low-stress, nonhuman primate tethering system for evaluation of SIVmac251 infection in rhesus macaques. A synergy between mucosal inflammation and SIV infection during periodontal inflammation points at potential implications for long-term pathogenesis.
Vascular disorders:
In collaborative efforts we study vascular disorders, mainly in baboons. Ischemia due to vascular ligation mobilizes multiple types of cells with distinct roles. We found that CD146+ cells from baboons may provide a source for therapeutic application, since they exhibit higher reparative capacity than CD34+ cells. Resveratrol, a drug with cardio-protective effects, may have potential in the prevention or treatment of inflammatory vascular disease. We confirmed specified CD34+ endothelial progenitor cells as promising therapeutic agents for repairing damaged vasculature.
Betamethasone studies
Betamethasone treatment of pregnant female baboons showed that it affects components of the fetal and maternal immune system and alters the maternal cytotoxic T and NK populations. By studying blood of the prematurely born baboon, we discovered monocyte-stimulated PDGF-B production as a potential mediator of smooth muscle cell migration during ductus closure.
We studied how diets affect blood vessels and impacts the development of cardiovascular diseases by observing endothelial-derived particles in blood during a dietary challenge. We detected endothelial damage by circulating particles in baboons on a diet high in simple carbohydrates and saturated or unsaturated fat.